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Background: Chest pain accounts for 6 million emergency room visits per year in the USA. Difficulty in diagnosing ischemia has led to a wide 
variety of available stress testing modalities.
The goal of stress testing in the ER is to rapidly and cost-effectively stratify patients who require urgent therapy, from those who may be safely sent 
home for outpatient management. We performed a critical analysis to quantify the impact of modality on cost and time expenditure in a real-world 
setting.
Methods: We reviewed charts and itemized billing records for all adult patients undergoing diagnostic stress tests: treadmill electrocardiography 
(ETT); exercise or pharmacologic echocardiography (ECHO) and nuclear studies (SPECT), after presenting to the emergency room in a 1-year period 
(N=509). Patients with acute myocardial infarction or a conclusive, noncardiac diagnosis were excluded. ANOVA, Tukey, and Fisher’s test were used.
Results: Medicaid (21%), Medicare (21%) and uninsured (5.1%) occupied a large proportion of the patients. Of 509 patients (225 male, 284 
female; mean age 56.8), 404 (79%) tests were negative for ischemia, 54 (10%) positive, and 51(11%) indeterminate. There were 82 ETT, 212 ECHO 
and 213 SPECT. There was no significant difference in the proportion of indeterminate results among the various stress tests. ETT led to the least 
total hospitalization cost and also the shortest hospital stay (mean $8,136; 27.0 hrs). ECHO was intermediate ($11,448; 33.4 hrs). SPECT was 
the most costly and least timely ($14,169; 42.7 hrs). Costs and time were increased by the addition of dobutamine to echocardiography ($1763; 
9.2 hrs) or vasodilator agent to nuclear imaging ($2631; 14.3 hrs). There was a poor correlation of the number of cardiac risk factors with study 
outcome (r = 0.105).
Conclusions: History and physical alone are insufficient to reliably diagnose ischemia, therefore stress tests are indispensable. Exercise tests 
incurred significantly lower cost and time compared with pharmacologic tests, and nuclear imaging was significantly more costly and time 
consuming than echocardiography. We recommend exercise over pharmacology; ETT over ECHO, and ECHO over SPECT for patients with chest pain in 
the ER.
